Altimmune Inc (NASDAQ: ALT) – Suitable For Long Term Buy?
Currently, there are 53.73M common shares owned by the public and among those 53.12M shares have been available to trade. Insiders at the company have transacted a total of 9 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 9 of these insider trades were purchases, […]
Analyst Expect Big Moves From Altimmune Inc (NASDAQ: ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
Reassessing The Changing Outlook For Altimmune Inc (ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $38.71 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT) Is Getting Increasingly Hard To Ignore
With over 10.36 million Altimmune Inc (ALT) shares trading Friday and a closing price of $11.19 on the day, the dollar volume was approximately $115.9 million. The shares have shown a positive half year performance of 240.12% and its price on 01/05/24 lost nearly -4.28%. Currently, there are 53.73M common shares owned by the public […]
Uncovering Institutional Buying In Altimmune Inc (NASDAQ: ALT)
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT): The Best-Of-Breed For Investing?
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT): Stock That Needs Special Handling
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.40% valued currently at $10.87 million. In addition, The Vanguard Group, […]
Is Altimmune Inc (NASDAQ: ALT) Back In The Buying Zone?
BlackRock Fund Advisors recently announced the acquisition of new stake in Altimmune Inc (NASDAQ:ALT). The institutional investor has increased its shareholding in the Healthcare company by 2.36% to 3.44 million shares with purchase of 79241.0 shares. This fresh investment now brings its stake to 6.53% valued currently at $8.29 million. In addition, The Vanguard Group, […]
Altimmune Inc (NASDAQ: ALT) Is Getting Increasingly Hard To Ignore
With over 52.73 million Altimmune Inc (ALT) shares trading Monday and a closing price of $4.63 on the day, the dollar volume was approximately $244.15 million. The shares have shown a positive half year performance of 8.43% and its price on 12/04/23 gained nearly 29.69%. Currently, there are 53.73M common shares owned by the public […]
